On April 1, 2026, China implemented a landmark national standard: Classification and Determination of TCM Constitution. Although designated as a recommended rather than mandatory standard, it represents a major step in modernizing traditional Chinese medicine (TCM) by converting traditional constitution theory into a clear, measurable and clinically practical framework. By clarifying the relationship between constitution, disease, and pattern differentiation, the standard strengthens professional credibility, supports research, and enhances patient-centered treatment.
Sheldon Li, PhD
Dr. Sheldon Li is the chairman of ActiveHerb Technology, Inc. (www.ActiveHerbWholesale.com). He received his PhD in molecular biology with honor from the University of Zurich and conducted cutting-edge research at Yale, UCSD and the Scripps Research Institute. He has made numerous original scientific discoveries, which have been published in prestigious scientific journals like Nature. His seminal discoveries are featured in the Molecular Biology of the Gene, an influential textbook studied by biomedical students in the U.S. and around the world. He sees TCM is undervalued by the mainstream science and now devotes himself to communicating the enormous value of TCM to the public.